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Data on stage, grade and morphology of 12761 colorectal cancers registered between 1995 and 2003 by Oxford Cancer Registry
are reviewed. Dukes stage is recorded for 81% of colon cancers and for 69% of rectal cancers. Incomplete registry data and changing
recording practices may affect future evaluation of bowel cancer screening.
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The UK NHS Bowel Cancer Screening Programme (http://
www.cancerscreening.nhs.uk/bowel) was introduced this year. In
order to evaluate its impact on incidence and mortality for
colorectal cancer, reliable data will be needed on trends in
registrations for cancers of the colon and rectum, and in particular
on tumour stage distribution, before and after the introduction of
screening. Tumour stage is the main determinant of survival from
colorectal cancer, and is expected to change substantially with
screening. Data on stage and grade have formed part of the
National Minimum Dataset for colorectal cancer collected by UK
Cancer Registries since 1995, but are not included in published
national statistics (Hayne et al, 2001; Quinn et al, 2001). We
describe data on colorectal cancer held by the Oxford Cancer
Intelligence Unit for the years 1995–2003.
MATERIALS AND METHODS
The Oxford Cancer Registry collects data on B1400 incident cases
of colorectal cancer each year in Berkshire, Buckinghamshire,
Northamptonshire and Oxfordshire (a population of B2.8
million). Since the early 1990s data have been obtained electro-
nically directly from hospital pathology, oncology and patient
administration records and from supplementary sources such as
private hospitals and the Office for National Statistics. For invasive
cancers of the colon (ICD10 C18) and of the rectum and related
sites (ICD10 C19–21) registered in 1995–2003, the following
variables were examined: year of diagnosis, age at diagnosis (in
years), sex, Dukes stage (A, B, C, D or not staged/not stageable),
grade (well, moderately, poorly or un-differentiated or not known)
and morphology (using a histological classification based on that
of WHO for tumours of the colon and rectum; Hamilton and
Aaltonen, 2000). Age-standardised registration rates were calcu-
lated by direct standardisation using the population of the
catchment area in 2000 as reference.
RESULTS
Between 1995 and 2003, a total of 12761 incident invasive
colorectal cancers, 7865 of the colon and 4896 of the rectum and
related sites (including 836 cancers of the rectosigmoid junction or
of colon with rectum, C19; 3778 of rectum, C20, and 282 of anus
and anal canal, C21), were registered. Characteristics of these
cancers are shown in Table 1. Classification by Dukes stage A–D
was available for 81% of C18 cancers and for 69% of C19–21
cancers; by grade for 76% of C18 and 81% of C19–21 tumours; and
by specified morphology for 86% of C18 and 92% of C19–C21.
Tumours classed by the registry as ‘unknown’ for any of these
variables include those recorded as ‘unstageable’ and those with
data missing. Data completeness did not show material variation
between men and women (Table 1) or by year of diagnosis; the
proportion of tumours of both colon and rectum classed as stage
unknown was higher in those over 75 years at diagnosis than in
younger patients (B25 vs B15%, respectively, for colon and B40
vs B25% for rectum). Age-standardised rates of registration of
colorectal cancer were higher in men than in women and higher
for colon than for rectal cancer throughout the period studied
(Figure 1). Overall rates and distribution of cancers by stage
remained relatively stable for the period 1995–2003 and particu-
larly so for the 5 years 1999–2003 (Figure 2).
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Detailed population-based evaluation of routine registry data will
be important for the accurate interpretation of changes in cancer
trends following the introduction of screening for colorectal
cancer. This study of data from one of the nine cancer registries in
England found that information on stage, grade and morphology
of tumours has been collected consistently for colorectal cancers
registered in the past 10 years. Registration rates and distribution
of cancers by stage, grade and morphology remained relatively
stable for the period 1995–2003. Data on morphology were
virtually complete for all cancers, but those on grade and stage
were not. In particular, information on stage was not available for
one-fifth of colon cancers and one-third of rectal cancers; and it
Table 1 Cancers of the colon (ICD-10 C18) and of the rectum and related sites (ICD-10 C19-21) registered by Oxford Cancer Registry, 1995–2003
C18 Female C18 Male C18 C19-21 Female C19-21 Male C19-21
Number of registrations 7865 3979 3886 4896 2076 2820
Mean age at diagnosis (years) 71.5 73.0 70.0 69.2 70.5 68.3
Dukes stage
A 590 (8%) 286 (7%) 304 (8%) 686 (14%) 297 (14%) 389 (14%)
B 2386 (30%) 1206 (30%) 1180 (30%) 1019 (21%) 388 (19%) 631 (22%)
C 2097 (27%) 1042 (26%) 1055 (27%) 1177 (24%) 465 (22%) 712 (25%)
D 1323 (17%) 665 (17%) 658 (17%) 479 (10%) 190 (9%) 289 (10%)
Unknown 1469 (19%) 780 (20%) 689 (18%) 1535 (31%) 736 (35%) 799 (28%)
Grade
Well differentiated 893 (11%) 435 (11%) 458 (12%) 634 (13%) 261 (13%) 373 (13%)
Moderately differentiated 4172 (53%) 2019 (51%) 2153 (55%) 2891 (59%) 1196 (58%) 1695 (60%)
Poorly differentiated 940 (12%) 511 (13%) 429 (11%) 451 (9%) 191 (9%) 260 (9%)
Undifferentiated 12 (o1%) 7 (o1%) 5 (o1%) 4 (o1%) 2 (o1%) 2 (o1%)
Unknown 1848 (24%) 1007 (25%) 841 (22%) 916 (19%) 426 (21%) 490 (17%)
Morphology
Adenocarcinoma
a 5978 (76%) 2915 (73%) 3063 (78%) 4014 (82%) 1630 (79%) 2384 (85%)
Mucinous adenocarcinoma
b 779 (10%) 407 (10%) 372 (10%) 252 (5%) 106 (5%) 146 (5%)
Squamous cell carcinoma 0 0 0 177 (4%) 111 (5%) 66 (2%)
Other specified epithelial 0 0 0 48 (1%) 30 (1%) 18 (o1%)
Epithelial NOS 1089 (14%) 649 (16%) 440 (11%) 385 (8%) 186 (9%) 199 (7%)
Non-epithelial 7 (o1%) 3 (o1%) 4 (o1%) 12 (o1%) 9 (o1%) 3 (o1%)
Neoplasm NOS 12 (o1%) 5 (o1%) 7 (o1%) 8 (o1%) 4 (o1%) 4 (o1%)
aIncludes two adenosquamous carcinomas.
bIncludes signet ring carcinoma. NOS¼not otherwise specified.
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Figure 1 Oxford Cancer Registry (1995–2003): age-standardised
registration rates for cancers of the colon (C18) and of the rectum and
related sites (C19–21), by sex.
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Figure 2 Oxford Cancer Registry (1995–2003): age-standardised
registration rates for cancers of the colon (C18) (A) and of the rectum
and related sites (C19–21) (B), by Dukes stage.
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by the pathologist as ‘unstageable’ and those with missing data.
This is a sufficiently high proportion of registered cancers to pose
potential problems in the interpretation of future trends in stage
registration in the context of the NHS Bowel Cancer Screening
Programme. Stage data for colorectal cancer in the Oxford registry
over the past decade have been consistently more complete than
the average for UK Cancer Registries. Current quality control
guidelines from the UK Association of Cancer Registries require
only a minimum of 74% stage completeness for colorectal cancer
(Department of Health, 2005) (a target higher than those for breast
and cervical cancers; for many tumours, including those for which
screening programmes may be considered in future, such as
prostate cancer, there has been until very recently no required
collection of stage data). Changes in cancer registration for
colorectal cancer will be affected not only by true changes in the
underlying incidence and stage distribution of cancers but also by
changes in recording practices by pathologists and by cancer
registries (Sharp, 2001). Some of these will be related to the
screening programme itself; either directly, for example differences
in data quality between screened and unscreened groups, or
indirectly, for example earlier diagnosis owing to increased
awareness of bowel cancer among doctors and among the public.
During the next several years, there may also be changes in
registration for all cancers as a result of increased and earlier
ascertainment, of continuing improvements in quality of data
collected by cancer registries and of the introduction of new data
capture technology related to NHS Connecting for Health (http://
www.icservices.nhs.uk/datasets/pages/cancer/). The current transi-
tion within cancer registration from use of Dukes stage to use of
the TNM classification for recording stage of colorectal cancer will
cause further problems. Some of these issues are illustrated in the
present data: the rise in registration of Dukes stage A cancers seen
between 1998 and 1999, and the corresponding fall in registrations
with stage unknown, may reflect concurrent changes in pathology
reporting, particularly of polyp tumours.
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